- Home
- GLTO vs WHLR Comparison
GLTO vs WHLR Comparison
Compare GLTO & WHLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLTO
- WHLR
- Stock Information
- Founded
- GLTO 2011
- WHLR 2011
- Country
- GLTO Denmark
- WHLR United States
- Employees
- GLTO N/A
- WHLR N/A
- Industry
- GLTO Biotechnology: Pharmaceutical Preparations
- WHLR Real Estate Investment Trusts
- Sector
- GLTO Health Care
- WHLR Real Estate
- Exchange
- GLTO Nasdaq
- WHLR Nasdaq
- Market Cap
- GLTO 6.5M
- WHLR 7.5M
- IPO Year
- GLTO 2020
- WHLR 2012
- Fundamental
- Price
- GLTO $5.50
- WHLR $2.26
- Analyst Decision
- GLTO Buy
- WHLR
- Analyst Count
- GLTO 1
- WHLR 0
- Target Price
- GLTO $10.00
- WHLR N/A
- AVG Volume (30 Days)
- GLTO 21.2K
- WHLR 4.7M
- Earning Date
- GLTO 03-07-2025
- WHLR 03-04-2025
- Dividend Yield
- GLTO N/A
- WHLR N/A
- EPS Growth
- GLTO N/A
- WHLR N/A
- EPS
- GLTO N/A
- WHLR N/A
- Revenue
- GLTO N/A
- WHLR $102,749,000.00
- Revenue This Year
- GLTO N/A
- WHLR N/A
- Revenue Next Year
- GLTO N/A
- WHLR N/A
- P/E Ratio
- GLTO N/A
- WHLR N/A
- Revenue Growth
- GLTO N/A
- WHLR N/A
- 52 Week Low
- GLTO $4.40
- WHLR $2.20
- 52 Week High
- GLTO $23.50
- WHLR $1,144.80
- Technical
- Relative Strength Index (RSI)
- GLTO 52.98
- WHLR 27.82
- Support Level
- GLTO $4.60
- WHLR $2.20
- Resistance Level
- GLTO $5.98
- WHLR $4.80
- Average True Range (ATR)
- GLTO 0.42
- WHLR 0.62
- MACD
- GLTO 0.08
- WHLR 0.21
- Stochastic Oscillator
- GLTO 65.22
- WHLR 2.31
About GLTO Galecto Inc.
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
About WHLR Wheeler Real Estate Investment Trust Inc.
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.